Parkinson's Disease Therapeutics Market Report

Global and China Parkinson's Disease Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 14, 2022
  • PAGES：181
  • REPORT CODE：GMM1464524
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • US WorldMeds

    • Akorn

    • Endo Pharmaceuticals

    • GSK

    • FHoffmann-La Roche

    • Stada Arzneimittel

    • Merck

    • Desitin Arzneimittel

    • Kyowa Hakko Kirin Pharma

    • HLundbeck

    • Apokyn

    • Boehringer Ingelheim

    • Valeant Pharmaceuticals

    • Astellas Pharma

    • Orion

    • Valeant

    • Novartis

    • Teva Pharmaceutical

    • Astellas Pharma Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Medications Therapeutics

    • Medical Devices Therapeutics

    Application:

    • Under 40 Years Old

    • 40-65 Years Old

    • Above 65 Years Old

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson's Disease Therapeutics Industry Overview

      • 1.1.1 Parkinson's Disease Therapeutics Market Scope and Market Segments

      • 1.1.2 Parkinson's Disease Therapeutics Industry Characteristics

      • 1.1.3 Global and China Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson's Disease Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Medications Therapeutics

      • 1.2.2 Medical Devices Therapeutics

    • 1.3 Global Parkinson's Disease Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Under 40 Years Old

      • 1.3.2 40-65 Years Old

      • 1.3.3 Above 65 Years Old

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson's Disease Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson's Disease Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson's Disease Therapeutics Industry PEST Analysis

    • 2.3 Parkinson's Disease Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson's Disease Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson's Disease Therapeutics Industry

    Chapter 3 Global and China Parkinson's Disease Therapeutics Market, by Manufacturer

    • 3.1 Global and China Parkinson's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson's Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson's Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson's Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson's Disease Therapeutics Market Top 3 Players

    Chapter 4 Global and China Parkinson's Disease Therapeutics Market, by Type (2017-2028)

    • 4.1 Parkinson's Disease Therapeutics Market Trend, by Type

    • 4.2 Global Parkinson's Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson's Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson's Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson's Disease Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson's Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson's Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson's Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson's Disease Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson's Disease Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson's Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson's Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson's Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson's Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson's Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson's Disease Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson's Disease Therapeutics Market Analysis

    • 7.1 North America Parkinson's Disease Therapeutics Market, by Type

    • 7.2 North America Parkinson's Disease Therapeutics Market, by Application

    • 7.3 North America Parkinson's Disease Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson's Disease Therapeutics Market Analysis

    • 8.1 Europe Parkinson's Disease Therapeutics Market, by Type

    • 8.2 Europe Parkinson's Disease Therapeutics Market, by Application

    • 8.3 Europe Parkinson's Disease Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson's Disease Therapeutics Market Analysis

    • 9.1 APAC Parkinson's Disease Therapeutics Market, by Type

    • 9.2 APAC Parkinson's Disease Therapeutics Market, by Application

    • 9.3 APAC Parkinson's Disease Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson's Disease Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson's Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson's Disease Therapeutics Company Profiles

      • 11.1 US WorldMeds

        • 11.1.1 US WorldMeds Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 US WorldMeds Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.1.3 US WorldMeds Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Akorn

        • 11.2.1 Akorn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Akorn Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Akorn Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Endo Pharmaceuticals

        • 11.3.1 Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GSK

        • 11.4.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GSK Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.4.3 GSK Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 FHoffmann-La Roche

        • 11.5.1 FHoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 FHoffmann-La Roche Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.5.3 FHoffmann-La Roche Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Stada Arzneimittel

        • 11.6.1 Stada Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Stada Arzneimittel Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Merck

        • 11.7.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Merck Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Merck Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Desitin Arzneimittel

        • 11.8.1 Desitin Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Kyowa Hakko Kirin Pharma

        • 11.9.1 Kyowa Hakko Kirin Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 HLundbeck

        • 11.10.1 HLundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 HLundbeck Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.10.3 HLundbeck Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Apokyn

        • 11.11.1 Apokyn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Apokyn Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.11.3 Apokyn Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Boehringer Ingelheim

        • 11.12.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.12.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Valeant Pharmaceuticals

        • 11.13.1 Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.13.3 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Astellas Pharma

        • 11.14.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Astellas Pharma Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.14.3 Astellas Pharma Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Orion

        • 11.15.1 Orion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Orion Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.15.3 Orion Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Valeant

        • 11.16.1 Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Valeant Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.16.3 Valeant Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Novartis

        • 11.17.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Novartis Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.17.3 Novartis Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Teva Pharmaceutical

        • 11.18.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.18.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Astellas Pharma Pharmaceuticals

        • 11.19.1 Astellas Pharma Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Astellas Pharma Pharmaceuticals Parkinson's Disease Therapeutics Product Profiles, Application and Specification

        • 11.19.3 Astellas Pharma Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson's Disease Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson's Disease Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson's Disease Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate of Medications Therapeutics (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate of Medical Devices Therapeutics (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate of Under 40 Years Old (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate of 40-65 Years Old (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Growth Rate of Above 65 Years Old (2017-2028)

    • Figure North America Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson's Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson's Disease Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson's Disease Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table China Parkinson's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table US WorldMeds Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table US WorldMeds Product Profiles, Application and Specification

    • Table US WorldMeds Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Akorn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Akorn Product Profiles, Application and Specification

    • Table Akorn Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Endo Pharmaceuticals Product Profiles, Application and Specification

    • Table Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table FHoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table FHoffmann-La Roche Product Profiles, Application and Specification

    • Table FHoffmann-La Roche Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Stada Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Stada Arzneimittel Product Profiles, Application and Specification

    • Table Stada Arzneimittel Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Desitin Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Desitin Arzneimittel Product Profiles, Application and Specification

    • Table Desitin Arzneimittel Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyowa Hakko Kirin Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyowa Hakko Kirin Pharma Product Profiles, Application and Specification

    • Table Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table HLundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HLundbeck Product Profiles, Application and Specification

    • Table HLundbeck Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Apokyn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Apokyn Product Profiles, Application and Specification

    • Table Apokyn Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Orion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orion Product Profiles, Application and Specification

    • Table Orion Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Product Profiles, Application and Specification

    • Table Valeant Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Pharmaceuticals Product Profiles, Application and Specification

    • Table Astellas Pharma Pharmaceuticals Parkinson's Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US